These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 5473222

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F.
    Med Welt; 1967 Aug 12; 32():1848-60. PubMed ID: 5589916
    [No Abstract] [Full Text] [Related]

  • 3. Clofibrate and androsterone effect on serum lipids.
    Orgain ES, Bogdonoff MD, Cain C.
    Arch Intern Med; 1967 Jan 12; 119(1):80-5. PubMed ID: 6015838
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV.
    Ter Arkh; 1968 Mar 12; 40(3):15-20. PubMed ID: 4875984
    [No Abstract] [Full Text] [Related]

  • 5. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G, Gibelli A, Giarola P.
    Clin Ter; 1966 Jul 15; 38(1):27-38. PubMed ID: 4230052
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S, Paparella P, Seu V.
    Clin Ter; 1969 Jul 15; 50(1):11-26. PubMed ID: 4917326
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Further data on the use of a preparation with antisclerotic action in geriatrics].
    Solaro F, Zinnari A, Dinale M.
    G Gerontol; 1970 Mar 15; 18(3):177-84. PubMed ID: 5473220
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G.
    Med Klin; 1968 Jan 26; 63(4):139-42. PubMed ID: 5670163
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B, Monnier J.
    Praxis; 1969 Jun 24; 58(25):815-20. PubMed ID: 5819485
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H, Herbst M, Sandhofer F, Sailer S.
    Dtsch Med Wochenschr; 1967 Dec 15; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.